ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.27
0.27%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,311.45
-0.39%
Brent Oil
83.395
-0.60%
Bitcoin
65,749.82
-1.11%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Skye Bioscience Inc (QB) (SKYE)

  7. Skye Bioscience Inc (QB) (SKYE) News

Skye Bioscience (QB) (SKYE)

Skye Bioscience Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SKYE
DateTimeSourceHeadlineSymbolCompany
05/03/202400:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202423:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202423:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202421:23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202421:18Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202411:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202411:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202411:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
04/03/202411:15Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:SKYESkye Bioscience Inc (QB)
01/03/202423:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
12/02/202421:18Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
12/02/202417:08Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:SKYESkye Bioscience Inc (QB)
02/02/202421:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
31/01/202421:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SKYESkye Bioscience Inc (QB)
29/01/202413:02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
05/12/202322:04Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
07/11/202301:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
07/11/202301:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
07/11/202301:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
07/11/202301:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
07/11/202301:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
03/10/202321:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
03/10/202321:12Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsUSOTC:SKYESkye Bioscience Inc (QB)
07/09/202318:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SKYESkye Bioscience Inc (QB)
30/08/202302:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
30/08/202300:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
29/08/202323:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
29/08/202323:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
29/08/202323:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SKYESkye Bioscience Inc (QB)
 Showing the most relevant articles for your search:USOTC:SKYE

Your Recent History

LSE
SCE
Surface Transforms
LSE
BIRD
Blackbird
LSE
QBT
Quantum Blockchain Techn...
LSE
GKP
Gulf Keystone Petroleum
LSE
AAZ
Anglo Asian Mining
LSE
TERN
Tern
LSE
CHLL
Chill Brands
LSE
AFC
Afc Energy
LSE
CPX
Cap-xx
LSE
EEE
Empire Metals
LSE
VAST
Vast Resources
LSE
OXB
Oxford Biomedica
LSE
INSG
Insig Ai
LSE
THG
Thg
LSE
SBTX
Skinbiotherapeutics
LSE
JLP
Jubilee Metals
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved